132 related articles for article (PubMed ID: 3426683)
1. Metabolism of cyanamide to cyanide and an inhibitor of aldehyde dehydrogenase (ALDH) by rat liver microsomes.
Shirota FN; DeMaster EG; Kwon CH; Nagasawa HT
Alcohol Alcohol Suppl; 1987; 1():219-23. PubMed ID: 3426683
[TBL] [Abstract][Full Text] [Related]
2. Novel prodrugs of cyanamide that inhibit aldehyde dehydrogenase in vivo.
Shirota FN; Stevens-Johnk JM; DeMaster EG; Nagasawa HT
J Med Chem; 1997 Jun; 40(12):1870-5. PubMed ID: 9191964
[TBL] [Abstract][Full Text] [Related]
3. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
4. Inactivation mechanism of low-KM rat liver mitochondrial aldehyde dehydrogenase by cyanamide in vitro.
Pruñonosa J; Sagristá ML; Bozal J
Drug Metab Dispos; 1991; 19(4):787-92. PubMed ID: 1680656
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
6. Catalase mediated conversion of cyanamide to an inhibitor of aldehyde dehydrogenase.
DeMaster EG; Shirota FN; Nagasawa HT
Alcohol; 1985; 2(1):117-21. PubMed ID: 4040375
[TBL] [Abstract][Full Text] [Related]
7. Cyanide is a product of the catalase-mediated oxidation of the alcohol deterrent agent, cyanamide.
Shirota FN; DeMaster EG; Nagasawa HT
Toxicol Lett; 1987 Jun; 37(1):7-12. PubMed ID: 3590232
[TBL] [Abstract][Full Text] [Related]
8. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of low-Km rat liver mitochondrial aldehyde dehydrogenase by cyanamide in vitro. A catalase-mediated reaction.
Pruńonosa J; Sagristá ML; Bozal J
Biochem Pharmacol; 1989 Jul; 38(13):2099-105. PubMed ID: 2735948
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
11. The metabolic activation of cyanamide to an inhibitor of aldehyde dehydrogenase is catalyzed by catalase.
DeMaster EG; Shirota FN; Nagasawa HT
Biochem Biophys Res Commun; 1984 Jul; 122(1):358-65. PubMed ID: 6378202
[TBL] [Abstract][Full Text] [Related]
12. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
Lakshmi VM; Zenser TV; Davis BB
Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548
[TBL] [Abstract][Full Text] [Related]
13. The oxidation of acrolein by rat liver aldehyde dehydrogenases. Relation to allyl alcohol hepatotoxicity.
Rikans LE
Drug Metab Dispos; 1987; 15(3):356-62. PubMed ID: 2886311
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatic aldehyde dehydrogenases in the rat by calcium carbimide (calcium cyanamide).
Loomis CW; Brien JF
Can J Physiol Pharmacol; 1983 Sep; 61(9):1025-34. PubMed ID: 6640426
[TBL] [Abstract][Full Text] [Related]
15. Alterations in brain aldehyde dehydrogenase activity modify the locomotor effects produced by ethanol in rats.
Spivak K; Aragon CM; Amit Z
Alcohol Drug Res; 1987; 7(5-6):481-91. PubMed ID: 3620014
[TBL] [Abstract][Full Text] [Related]
16. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
[TBL] [Abstract][Full Text] [Related]
17. Use of cyanamide to determine localization of acetaldehyde metabolism in rat liver.
Svanas GW; Weiner H
Alcohol; 1985; 2(1):111-5. PubMed ID: 4015825
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic requirement for cyanamide inactivation of rat liver aldehyde dehydrogenase.
Svanas GW; Weiner H
Biochem Pharmacol; 1985 Apr; 34(8):1197-204. PubMed ID: 3994742
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of the aldehyde dehydrogenase inhibitors, disulfiram, pargyline and cyanamide, on circulating ketone body levels in the rat.
DeMaster EG; Stevens JM
Biochem Pharmacol; 1988 Jan; 37(2):229-34. PubMed ID: 3342079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
